Comparison · NCT04972123-b17aa04c
CPC Administration vs Placebo Administration: Percentage of Patients Who Have Asystolic Pauses > 3 Seconds in the CPC and Placebo Arms
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. CPC Administration vs Placebo Administration: Percentage of Patients Who Have Asystolic Pauses > 3 Seconds in the CPC and Placebo Arms. Trial comparisons, record NCT04972123-b17aa04c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04972123-b17aa04c
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0625 | 0.0173 | 0.201 | wilson | |
| Risk in group 2 | 0.037 | 0.00657 | 0.183 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0255 | -0.127 | 0.168 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.69 | 0.162 | 17.6 | log | |
| Odds ratio, group 1 over group 2 | 1.73 | 0.148 | 20.2 | log | |
| Number needed to treat, for one more participant with the outcome on CPC Administration than on Placebo Administration | 39.3 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | CPC Administration | Participants randomized to receive CPC who experienced an event | 2 | 32 | OG000 |
| Group 2 | Placebo Administration | Participants randomized to receive Placebo who experienced an event | 1 | 27 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Percentage of Patients Who Have Asystolic Pauses > 3 Seconds in the CPC and Placebo Arms
- Description
- Percentage of Participants with an event who had asystolic pauses \> 3 seconds during syncope or near syncope
- Time frame
- During tilt table testing (up to approximately 35 minutes)
- Population
- Secondary endpoints analyses were limited to participants who had syncope or near syncope
Source ClinicalTrials.gov
Trial
- Title
- The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
- NCT number
- NCT04972123
- Phases
- PHASE2
- Conditions
- Syncope, Vasovagal
- Interventions
- CPC - Capsaicin, Phenylephrine, Caffeine, Tilt Table Test, Placebo
- Lead sponsor
- University of Wisconsin, Madison
- Results first posted
- 2024-06-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04972123?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04972123-b17aa04c